国际标准期刊号: 2376-127X

妊娠与儿童健康杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 学术钥匙
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Short-term Survival and Morbidity of Extremely premature Infants Born between 20 Weeks and 24 Weeks+6 Days Gestation

Souhail Alouini1*, Rasonandrianina Bienvenue Solange1, Anna Ramos1, Nabil Ayass2 and Rado Randriamboavonjy3

Objective: To evaluate the morbidity and mortality of extremely premature infants (EPIs) born between 20 weeks and 24 weeks+6 days gestation at hospital discharge. Methods: This was a retrospective study that included all extremely preterm births between 2006 and 2012 at a tertiary maternity care centre with a neonatal intensive care unit. Results: Seventy-eight EPIs were born during the study period out of 30,000 deliveries (0.26%). Thirty-nine EPIs (50%) survived and had a mean length of hospital stay of 43 days. The mean weight of EPIs was 723 ± 179 g. The rate of survival of EPIs increases with gestational age. Forty-nine EPIs (62%) exhibited neonatal respiratory distress (NNRD), which evolved into a bronchopulmonary dysplasia in 28 cases (35%); 33 EPIs (42%) had a maternofetal infection, while 20 (26%) experienced ventricular hemorrhage. Ten EPI (13%) displayed enterocolitis and 17 (22%) had retinopathy. No EPIs born before 22 weeks gestation survived Twenty-four EPIs left the hospital with their mothers after being scheduled for a routine paediatric follow-up visit and 15 were transferred to another hospital: 10 for surgical treatment of patent ductus arteriosus and 5 to be closer to their mothers. Conclusion: The survival rates of EPIs between 20 and 24 weeks of gestation are high. NNRD, infections, and neurological and retinal complications were the main causes of morbidity. The results of this active management study of extremely preterm births were satisfactory at the short follow-up visits. Antenatal corticosteroids and magnesium sulfate administration should be discussed beginning at 22 weeks of gestation.